Inhibition of PFKFB3 counteracts atherosclerosis via NLRP3/Casepase1/IL-1β pathway in macrophages

被引:0
|
作者
Zhao, M. [1 ]
Wang, X. [2 ]
Wu, W. [1 ]
Bai, Y. [2 ]
Li, X. [3 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China
[3] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Gided Therapy, Vienna, Austria
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0016
引用
收藏
页码:S437 / S437
页数:1
相关论文
共 50 条
  • [1] The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages
    Finucane, Orla M.
    Sugrue, Jamie
    Rubio-Araiz, Ana
    Guillot-Sestier, Marie-Victoire
    Lynch, Marina A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages
    Orla M. Finucane
    Jamie Sugrue
    Ana Rubio-Araiz
    Marie-Victoire Guillot-Sestier
    Marina A. Lynch
    Scientific Reports, 9
  • [3] NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
    Grebe, Alena
    Hoss, Florian
    Latz, Eicke
    CIRCULATION RESEARCH, 2018, 122 (12) : 1722 - 1740
  • [4] VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages
    Huang, Xiaoyong
    Feng, Zeqing
    Jiang, Yuanzhong
    Li, Jialin
    Xiang, Qun
    Guo, Sheng
    Yang, Chengying
    Fei, Lei
    Guo, Guoning
    Zheng, Lixin
    Wu, Yuzhang
    Chen, Yongwen
    SCIENCE ADVANCES, 2019, 5 (01):
  • [5] NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?
    Chen, Xu
    Zhang, Dongxing
    Li, Yuping
    Wang, Weixuan
    Bei, Weijian
    Guo, Jiao
    PHARMACOLOGICAL RESEARCH, 2021, 173
  • [6] IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages
    Gicquel, Thomas
    Robert, Sacha
    Loyer, Pascal
    Victoni, Tatiana
    Bodin, Aude
    Ribault, Catherine
    Gleonnec, Florence
    Couillin, Isabelle
    Boichot, Elisabeth
    Lagente, Vincent
    FASEB JOURNAL, 2015, 29 (10): : 4162 - 4173
  • [7] NLRP3 and IL-1β in macrophages as critical regulators of metabolic diseases
    McGettrick, A. F.
    O'Neill, L. A. J.
    DIABETES OBESITY & METABOLISM, 2013, 15 : 19 - 25
  • [8] A new mechanism of inhibition of IL-1β secretion by celastrol through the NLRP3 inflammasome pathway
    Xin, Wenyu
    Wang, Qiaoyun
    Zhang, Dan
    Wang, Chaoyun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 814 : 240 - 247
  • [9] NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
    Zhong, Chaoqing
    Wang, Ruiqing
    Hua, Mingqiang
    Zhang, Chen
    Han, Fengjiao
    Xu, Miao
    Yang, Xinyu
    Li, Guosheng
    Hu, Xiang
    Sun, Tao
    Ji, Chunyan
    Ma, Daoxin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Remimazolam alleviates myocardial ischemia/reperfusion injury and inflammation via inhibition of the NLRP3/IL-1β pathway in mice
    Liu, Xueru
    Shui, Guojing
    Wang, Yan
    Chen, Tangting
    Zhang, Peng
    Liu, Li
    Li, Chunhong
    Li, Tao
    Wang, Xiaobin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (04)